121 related articles for article (PubMed ID: 38377379)
1. Small Cell Neuroendocrine Carcinoma of the Prostate on 18 F-DCFPyL and 18 F-FDG PET/CT.
Li E; Russon A; Chen J; Mansberg V; Mansberg R
Clin Nucl Med; 2024 Apr; 49(4):335-337. PubMed ID: 38377379
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study.
Lucas Lucas C; García Zoghby L; Amo-Salas M; Soriano Castrejón ÁM; García Vicente AM
Ann Nucl Med; 2023 Oct; 37(10):551-560. PubMed ID: 37532975
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT Findings of a Small Cell Carcinoma of the Lung Presented as Diffuse Dermatomyositis.
Li X; Tian B; Bai X
Clin Nucl Med; 2024 Apr; 49(4):379-380. PubMed ID: 38427959
[TBL] [Abstract][Full Text] [Related]
5. Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma.
Rowe SP; Gorin MA; Hammers HJ; Pomper MG; Allaf ME; Javadi MS
Clin Nucl Med; 2016 Jan; 41(1):83-5. PubMed ID: 26402128
[TBL] [Abstract][Full Text] [Related]
6. Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma.
Gu J; Lu Y; Xu G
Clin Nucl Med; 2022 Mar; 47(3):255-257. PubMed ID: 34392287
[TBL] [Abstract][Full Text] [Related]
7. Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.
Mena E; Shih J; Chung JY; Jones J; Rabiee A; Monge C; Turkbey B; Lindenberg L; Salerno KE; Kassin M; Wood B; Hernandez J; Maass-Moreno R; Saboury B; Jakhete N; Molitoris JK; Unger KR; Choyke PL; Escorcia FE
PLoS One; 2022; 17(11):e0277407. PubMed ID: 36367894
[TBL] [Abstract][Full Text] [Related]
8.
Ulaner GA; Thomsen B; Bassett J; Torrey R; Cox C; Lin K; Patel T; Techasith T; Mauguen A; Rowe SP; Lindenberg L; Mena E; Choyke P; Yoshida J
Radiology; 2022 Nov; 305(2):419-428. PubMed ID: 35852431
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous uptake of
Hu Y; Wang P; Dai W
BMC Pulm Med; 2023 Mar; 23(1):73. PubMed ID: 36882747
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Liu Y; Wang G; Yu H; Wu Y; Lin M; Gao J; Xu B
Nucl Med Commun; 2020 Dec; 41(12):1299-1305. PubMed ID: 32941403
[TBL] [Abstract][Full Text] [Related]
12. Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation.
Broos WAM; Kocken M; van der Zant FM; Knol RJJ; Wondergem M
Clin Nucl Med; 2018 Feb; 43(2):120-122. PubMed ID: 29261618
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.
Liu W; Zukotynski K; Emmett L; Chung HT; Chung P; Wolfson R; Rachinsky I; Kapoor A; Metser U; Loblaw A; Morton G; Sexton T; Lock M; Helou J; Berlin A; Boylan C; Archer S; Pond GR; Bauman G
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):546-555. PubMed ID: 31730876
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
Zukotynski KA; Jadvar H; Potvin K; Cho SY; Kim CK; Winquist E
Clin Nucl Med; 2020 Sep; 45(9):727-729. PubMed ID: 32520499
[TBL] [Abstract][Full Text] [Related]
15. Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
Signorelli M; Guerra L; Pirovano C; Crivellaro C; Fruscio R; Buda A; Cuzzucrea M; Elisei F; Ceppi L; Messa C
Gynecol Oncol; 2013 Nov; 131(2):395-9. PubMed ID: 23988414
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
Albano D; Bosio G; Treglia G; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):77-84. PubMed ID: 28822997
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
[TBL] [Abstract][Full Text] [Related]
18. Granulomatous Lymphangitis Masquerading as Relapsed Hodgkin Disease on FDG PET/CT.
Mustafa M; Patel D; Shen L; Shetty A; Mansberg R
Tomography; 2018 Mar; 4(1):1-3. PubMed ID: 30042982
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PSMA-based
Nguyen TT; Bhosale PR; Xu G; Pan T; Wei P; Lu Y
Am J Nucl Med Mol Imaging; 2022; 12(6):166-179. PubMed ID: 36636233
[TBL] [Abstract][Full Text] [Related]
20. Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of Biochemically Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis.
Sun J; Lin Y; Wei X; Ouyang J; Huang Y; Ling Z
Front Oncol; 2021; 11():649171. PubMed ID: 33981607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
